← Open Payments lookup

JOHN ANOOSHIAN: Open Payments

NPI 1235189705 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$153,651 in 361 payments from 12 companies in 2025. Trend: 2023 $129,851 · 2024 $201,696 · 2025 $153,651

Speaker / faculty: $108,511Travel & lodging: $25,260Consulting: $11,903Food & beverage: $7,977
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.103$60,396
Janssen Pharmaceuticals, Inc123$55,179
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)68$34,949
E.R. Squibb & Sons, L.L.C.24$1,903
Otsuka America Pharmaceutical, Inc.18$347
Alkermes, Inc.11$273
ABBVIE INC.6$181
Avadel CNS Pharmaceuticals, LLC1$150
Janssen Scientific Affairs, LLC1$131
Teva Pharmaceuticals USA, Inc.4$92

Products named: INGREZZA, INVEGA SUSTENNA, CAPLYTA, COBENFY, ARISTADA, ABILIFY ASIMTUFII, VRAYLAR, LUMRYZ.

Industry payments across NV — which companies pay providers there.